Stage IVB Cervical Cancer Completed Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028787 (Stage IVB Cervical Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064077Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixTreatment
NCT00803062Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerTreatment